OBJECTIVE: Paired-exchange kidney transplantation (PETx) gains an importance because it is difficult to find suitable organs. The aim of this study was to compare biochemical and clinical parameters of PETx with those of living-related kidney transplantation (LRTx). METHOD: The 57 PETx included 18 female and 39 male recipients among 1081 LRTx in 360 females and 721 males (N = 1138) whose operations were performed between November 21, 2008, and March 1, 2011. These two groups were compared for graft and patient survival, rejections, serum creatinine levels, glomerular filtration rates (GFRs), and other biochemical parameters. RESULTS: The PETx patients were older than the LRTx patients (45.4 ± 13.2 years versus 40.9 ± 13.5 years; P = .014). HLA mismatch was higher in the PETx group (4.7 ± 0.7 versus 3.56 ± 1.6; P = .000). First- and second-year serum creatinine and GFR values were similar between the two groups. Acute rejection episodes (PETx: 13/57; LRTx: 226/1081, P = .925), patient loss (0/57 versus 34/1081; P = .174) and graft loss (1/57 versus 55/1081; P = .257) were similar between the two groups. CONCLUSION: Our study showed similar biochemical and clinical findings of PETx versus LRTx over 2 years posttransplantation.
OBJECTIVE: Paired-exchange kidney transplantation (PETx) gains an importance because it is difficult to find suitable organs. The aim of this study was to compare biochemical and clinical parameters of PETx with those of living-related kidney transplantation (LRTx). METHOD: The 57 PETx included 18 female and 39 male recipients among 1081 LRTx in 360 females and 721 males (N = 1138) whose operations were performed between November 21, 2008, and March 1, 2011. These two groups were compared for graft and patient survival, rejections, serum creatinine levels, glomerular filtration rates (GFRs), and other biochemical parameters. RESULTS: The PETxpatients were older than the LRTxpatients (45.4 ± 13.2 years versus 40.9 ± 13.5 years; P = .014). HLA mismatch was higher in the PETx group (4.7 ± 0.7 versus 3.56 ± 1.6; P = .000). First- and second-year serum creatinine and GFR values were similar between the two groups. Acute rejection episodes (PETx: 13/57; LRTx: 226/1081, P = .925), patient loss (0/57 versus 34/1081; P = .174) and graft loss (1/57 versus 55/1081; P = .257) were similar between the two groups. CONCLUSION: Our study showed similar biochemical and clinical findings of PETx versus LRTx over 2 years posttransplantation.
Authors: Vivek B Kute; Sanjay K Agarwal; Manisha Sahay; Anant Kumar; Manish Rathi; Narayan Prasad; Rajkumar K Sharma; Krishan L Gupta; Sunil Shroff; Sandip K Saxena; Pankaj R Shah; Pranjal R Modi; Vishwanath Billa; Laxmikant K Tripathi; Sreebhushan Raju; Dhamedndra S Bhadauria; Tarun K Jeloka; Dhananjai Agarwal; Amresh Krishna; Rajshekhar Perumalla; Manoj Jain; Sandeep Guleria; Michael A Rees Journal: Indian J Nephrol Date: 2018 Jan-Feb